Psychedelic-Assisted Therapy in Palliative Care—Insights from an International Workshop

<b>Background:</b> Evidence is growing that psychedelic substances have positive effects in the setting of Palliative Care (PC), focusing on special needs in this patient population. After a scoping review of the literature, no published expert recommendations guiding best practice for psychedelic-assisted therapy (PAT) towards the end of life were identified. <b>Objective:</b> To draw conclusions from first-hand experienced professionals on PAT in PC (PATPC). <b>Setting, Design, Participants:</b> An international workshop with experts was held in Wasserfallen, Switzerland. A thematic analysis of a semi-structured, questionnaire-based qualitative study with 13 experts in PC, oncology, psychiatry/psychology, and PAT from Europe, the United States, and Oceania was made. <b>Measurements:</b> The questionnaire was designed to elicit the participant's perspectives on (A) special considerations on PATPC, (B) specific characteristics of PATPC (versus mental illness), and (C) the relevance of these differences during preparation, substance dosing session, and integration in PATPC. <b>Results:</b> (A) Special Considerations included (non-medicalized) setting, potential need, and possibility to reduce preparation time. (B) Distinguishing characteristics included the patient's intrinsic motivation for treatment success, the importance of anxiety, depression, and spiritual distress as indications for PATPC, and the importance of sufficient integration of the psychedelic experience into life in the face of limited time due to the life-limiting illness. (C) Flexibility in setting and timing of preparation, choosing the appropriate dosage of the psychedelic substance depending on the patient's intended focus, low/medium (relational issues), higher for transcendental experiences, considering mental capacity and vulnerability for the individual. In addition, respondents noted that for therapists, knowledge about transcendental states, such as mystical experiences, existential aspects of life-threatening illness, and the role of therapists' own self-experience/inner work, as well as good knowledge of the theoretical basis for treatment, was highlighted. <b>Conclusions:</b> This study highlights special considerations for PAT PC and could be a first step towards specific treatment recommendations (guidelines) for PATPC.

Authors

Institutions

Publication Details

Journal
Healthcare
Published
2025-09-12
DOI
https://doi.org/10.3390/healthcare13182275
Primary Topic
Psychedelics and Drug Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Psychedelic-Assisted Therapy in Palliative Care—Insights from an International Workshop

Yasmin Schmid, Sivan Schipper, Christopher Boehlke, Ian C. Clark et al.
Healthcare
Psychedelics and Drug Studies
article

Psychedelic-Assisted Therapy in Palliative Care—Insights from an International Workshop

Yasmin Schmid, Sivan Schipper, Christopher Boehlke, Ian C. Clark, Anna Schuldt, Michael Ljuslin, Megan B. Sands, David Blum
article en

Abstract

<b>Background:</b> Evidence is growing that psychedelic substances have positive effects in the setting of Palliative Care (PC), focusing on special needs in this patient population. After a scoping review of the literature, no published expert recommendations guiding best practice for psychedelic-assisted therapy (PAT) towards the end of life were identified. <b>Objective:</b> To draw conclusions from first-hand experienced professionals on PAT in PC (PATPC). <b>Setting, Design, Participants:</b> An international workshop with experts was held in Wasserfallen, Switzerland. A thematic analysis of a semi-structured, questionnaire-based qualitative study with 13 experts in PC, oncology, psychiatry/psychology, and PAT from Europe, the United States, and Oceania was made. <b>Measurements:</b> The questionnaire was designed to elicit the participant's perspectives on (A) special considerations on PATPC, (B) specific characteristics of PATPC (versus mental illness), and (C) the relevance of these differences during preparation, substance dosing session, and integration in PATPC. <b>Results:</b> (A) Special Considerations included (non-medicalized) setting, potential need, and possibility to reduce preparation time. (B) Distinguishing characteristics included the patient's intrinsic motivation for treatment success, the importance of anxiety, depression, and spiritual distress as indications for PATPC, and the importance of sufficient integration of the psychedelic experience into life in the face of limited time due to the life-limiting illness. (C) Flexibility in setting and timing of preparation, choosing the appropriate dosage of the psychedelic substance depending on the patient's intended focus, low/medium (relational issues), higher for transcendental experiences, considering mental capacity and vulnerability for the individual. In addition, respondents noted that for therapists, knowledge about transcendental states, such as mystical experiences, existential aspects of life-threatening illness, and the role of therapists' own self-experience/inner work, as well as good knowledge of the theoretical basis for treatment, was highlighted. <b>Conclusions:</b> This study highlights special considerations for PAT PC and could be a first step towards specific treatment recommendations (guidelines) for PATPC.

HealthcareVol. 13(18)
University of Geneva (CH), University of Basel (CH), University of Zurich (CH), University Hospital of Basel (CH), UNSW Sydney (AU), University Hospital of Zurich (CH), University Hospital of Geneva (CH), Calvary Mater Newcastle Hospital (AU), Bethesda Spital (CH), Spital Uster (CH), Geneva College (US)
Openalex Percentile: Top 65%
Psychedelics and Drug Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.